Quantum Genomics【ALQGC】銘柄情報

Quantum Genomics (ALQGC) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.072

( - )

買値

0.072

売値

0.072

出来高

0.00

平均取引量 (3 か月)

0.00 €

財務取引量

0.00 日の範囲 0.00

0.072 52 週間の範囲 0.0722

時価総額

5.019M

企業価値

7.357M

前日終値

0.072

始値

時刻

最終取引時間

VWAP

歳入

純利益

-8.89M

発行済株式数

69,709,954

浮動株比率 (%)

85.66%

機関投資家保有比率 (%)

14.34%

配当利回り

PER

-0.56

株価売上高倍率 (PSR)

501.91k

1 株当たり利益 (EPS)

-0.13

ベータ

-0.15

Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France. Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.

セクター

Health Care

業界

ウェブサイト

quantum-genomics.com

本社

Paris, France

設立

2026

Quantum Genomics is listed in the Health Care sector of the ユーロネクスト with ticker ALQGC. The last closing price for Quantum Genomics was 0.07 €. Over the last year, Quantum Genomics shares have traded in a share price range of 0.072 € to 0.0722 €.

Quantum Genomics currently has 69,709,954 shares in issue. The market capitalisation of Quantum Genomics is 5.02 € million. Quantum Genomics has a price to earnings ratio (PE ratio) of -0.56.

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in...

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.072	0.072	0.072	0	0	DE
4	0	0	0.072	0.072	0.072	0	0	DE
12	0	0	0.072	0.072	0.072	0	0	DE
26	-0.0002	-0.277008310249	0.0722	0.0722	0.072	0	0	DE
52	-0.0002	-0.277008310249	0.0722	0.0722	0.072	0	0	DE
156	-0.0806	-52.8178243775	0.1526	0.195	0.001	171876	0.06461482	DE
260	-3.856	-98.16700611	3.928	6.185	0.001	220888	0.9281391	DE